Releaf Blog
Discover helpful insights on health, wellness, and medical cannabis in our blogs. Explore practical articles covering general medical cannabis info, tips for staying well, and how medical cannabis can assist with specific health conditions.
Latest
Decoding Cannabis: what a recent scoping review reveals about cannabis for rheumatoid arthritis
A recent scoping review has dug into how cannabinoids interact with inflammation, joint tissue, and pain signalling in rheumatoid arthritis. This article breaks down what the researchers found, how THC and CBD influence key inflammatory pathways, and what these insights may mean for people living with arthritis in the UK. We also look at how this evidence compares with current patient experiences.
UK cannabis insights: The Releaf statistic series infographic
To get a deeper understanding of the medical cannabis industry in the UK, we’ve decided to investigate some of the key statistics that shape the cannabis landscape as we know it. The Releaf Medical Cannabis Statistic Series examined the impact of medical cannabis across three crucial domains: the economy, health, and society.
Thai government plans to scale back cannabis legalisation to medical-only
The Thai government has announced their intention to scale back cannabis legalisation in favour of regulations that support the use of cannabis as a medicine only. Newly elected Prime Minister Srettha Thavisin of the Pheu Thai Party has announced his plan to implement these changes quickly within the next six months with the backing of his 11-party coalition government.
Introducing Releaf’s Brand Ambassador: An interview with Dr Charlie Easmon
Dr Charlie Easmon is a highly acclaimed international health expert, who has ventured through over 75 countries, observing and evaluating local medical facilities for the last four decades.
A cause for concern: Home Affairs Committee calls for improvements in access to medical cannabis
For the second time in a matter of months, official organisations, in this case the Home Affairs Committee, have raised concerns to the government about issues in accessing cannabis-based medicines in the UK.